Full text is available at the source.
Gut microbiota profiling of pediatric nonalcoholic fatty liver disease and obese patients unveiled by an integrated meta‐omics‐based approach
Gut bacteria patterns in children with fatty liver disease and obesity revealed by combined analysis methods
AI simplified
Abstract
Stool samples from 61 pediatric patients with nonalcoholic fatty liver disease (NAFLD) showed significant changes in gut microbiota compared to 54 healthy controls.
- NAFLD patients exhibited increased levels of Actinobacteria and decreased levels of Bacteroidetes compared to healthy controls.
- The diversity of gut microbiota was highest in healthy controls, followed by obese, nonalcoholic steatohepatitis (NASH), and nonalcoholic fatty liver (NAFL) patients.
- Increased levels of Bradyrhizobium, Anaerococcus, Peptoniphilus, and Dorea were observed in NAFLD patients compared to controls.
- A decrease in Oscillospira was noted in both NAFL and NASH groups, while Ruminococcus and Dorea levels were higher in NASH patients compared to controls.
- Out of 292 volatile organic compounds analyzed, 26 were up-regulated and 2 down-regulated in NAFLD patients, with specific compounds identified as potential discriminators from controls.
AI simplified